Back

Sex differences in the long-term outcomes of moderate rheumatic mitral stenosis

2 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Diversity and specific populations in valvular heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Dae-Young Kim

Inha University Hospital, Incheon (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Socioeconomic disparity in utilization of transcatheter aortic valve replacement
Associate Professor Y. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Demographics and clinical outcomes of flow-gradient patterns of aortic stenosis: an analysis of the CURRENT AS Registry-2.
Doctor T. Taniguchi (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Inter-ethnic heterogeneity in valvular morphology and aortopathy of a worldwide bicuspid aortic valve cohort referred for TAVR
Doctor M. Barki (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Clinical impact of transcatheter aortic valve implantation (TAVI) in frail patients: a single-center prospective study
Doctor D. Martinez Lopez (Alicante, ES)
Abstract Slides Video
Presentation thumbnail
Symptoms of Anxiety and Depression (SAD) in patients undergoing transcatheter aortic valve implantation. A multicentre Australian experience: The SAD-TAVI Study
Doctor A. Butala (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Diversity and specific populations in valvular heart disease

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Sex-differences and long-term outcomes after aortic valve replacement
thumbnail
Congress Presentation
Sex differences in secondary prevention and outcomes post-myocardial infarction in Scotland.
thumbnail
Congress Presentation
Sex related differences in frequency, management and outcome of severe native valvular heart disease. Results from the ESC-EORP Valvular Heart Disease II survey

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources